All verified mentions of this organization in source documents.
LambdaVision won a NASA Phase 2 In Space Production Applications award in September to continue developing its in-space manufacturing process.
LambdaVision closed a $7 million seed round on Wednesday.
LambdaVision is continuing to raise money in anticipation of its Series A funding.
LambdaVision aims to help people living with retinal diseases that deteriorate over time.
LambdaVision announced the first closing of its seed round in May 2024.
LambdaVision continued research to produce an artificial retina using investigations on the International Space Station.
Space Tango launched an initial mission with LambdaVision to evaluate protein-based retinal implant production on orbit on the SpaceX Commercial Resupply Services-16 (CRS-16) mission from Cape Canaveral, Florida on 2018-12-05 at approximately 1:16 PM EST.
Space Tango is working with LambdaVision, a Farmington, Connecticut company, to test whether LambdaVision can produce retinal implants in microgravity.